Hyundai Bioscience Co., Ltd. (048410.KQ)

KRW 13990.0

(-1.82%)

Total Assets Summary of Hyundai Bioscience Co., Ltd.

  • Hyundai Bioscience Co., Ltd.'s latest annual total assets in 2023 was 52.79 Billion KRW , down -21.59% from previous year.
  • Hyundai Bioscience Co., Ltd.'s latest quarterly total assets in 2024 Q1 was 53.73 Billion KRW , up 1.78% from previous quarter.
  • Hyundai Bioscience Co., Ltd. reported annual total assets of 67.32 Billion KRW in 2022, down -16.39% from previous year.
  • Hyundai Bioscience Co., Ltd. reported annual total assets of 80.52 Billion KRW in 2021, down -14.09% from previous year.
  • Hyundai Bioscience Co., Ltd. reported quarterly total assets of 53.73 Billion KRW for 2024 Q1, up 1.78% from previous quarter.
  • Hyundai Bioscience Co., Ltd. reported quarterly total assets of 52.79 Billion KRW for 2023 Q4, down -13.24% from previous quarter.

Annual Total Assets Chart of Hyundai Bioscience Co., Ltd. (2023 - 2012)

Historical Annual Total Assets of Hyundai Bioscience Co., Ltd. (2023 - 2012)

Year Total Assets Total Assets Growth
2023 52.79 Billion KRW -21.59%
2022 67.32 Billion KRW -16.39%
2021 80.52 Billion KRW -14.09%
2020 93.74 Billion KRW 48.24%
2019 63.23 Billion KRW 17.08%
2018 54 Billion KRW 9.11%
2017 49.49 Billion KRW -7.27%
2016 53.38 Billion KRW 22.96%
2015 43.41 Billion KRW 32.33%
2014 32.8 Billion KRW 6.37%
2013 30.84 Billion KRW -3.8%
2012 32.06 Billion KRW 0.0%

Peer Total Assets Comparison of Hyundai Bioscience Co., Ltd.

Name Total Assets Total Assets Difference
Sam Chun Dang Pharm. Co., Ltd 408.02 Billion KRW 87.062%
ST Pharm Co.,Ltd. 686.83 Billion KRW 92.314%
ABL Bio Inc. 160.14 Billion KRW 67.035%
Cellid, Co., Ltd. 63.92 Billion KRW 17.413%